Transplant News back issues from Monday, June 14:
58 Senators urge President Bush to change stem cell research policy; Reagan death may have impact.
Jun 14, 2004; ... Pressure on President Bush to change his current stance on stem cell research increased significantly this past week when a majority of the US Senate, including 14 Republicans, sent him a letter urging him to loosen current restrictions on federal funding. The letter was signed ...
Excerpt from letter sent to President Bush signed by 58 US Senators.(Excerpt)
Jun 14, 2004 ... "We "As you know, embryonic stem cells have the potential to be used to treat and better understand deadly and disabling diseases and conditions that affect more than 100 million Americans, such as cancer, heart disease, diabetes, Parkinson's, Alzheimer's, multiple sclerosis, ...
WHO adopts recommendations designed to end "transplant tourism", "harmonize global practices".
Jun 14, 2004 ... Responding to recent reports of worldwide trafficking in organs for transplantation, the world's preeminent health policy making organization has called on countries to "harmonize global practices" to "ensure the ethical practice" of organ and tissue transplantation. Meeting ...
Effort to get initiative on California ballot in November to publicly finance stem cell research successful.
Jun 14, 2004 ... The drive to get an initiative on the California ballot seeking voter approval for $3 billion in public financing to fund embryonic stem cell research has been successful. (Transplant News, May 15, 2004) The California Secretary of State's office announced on June 3 that the ...
Adding stem cell therapy to bypass surgery improves heart function in patients with congestive heart failure.(Brief Article)
Jun 14, 2004 ... Adding stem cell therapy to bypass surgery further improves heart function in patients with congestive heart failure (CHF), physicians reported at the annual meeting of the American Association for Thoracic Surgery in Toronto. Amit Patel, MD and colleagues at the University of ...
New York Department of Health fines 2 transplant centers for violating state transplant policies.(Albany Medical Center Hospital (Albany, New York))(Strong Memorial Hospital )
Jun 14, 2004 ... Two New York transplant programs have been fined in the past 7 weeks by the New York State Department of Health (NYDH) for violating state organ donation and transplant policies. In late April the NYDH issued a $20,000 fine to Strong Memorial Hospital in Rochester for problems ...
CDC unveils new policies to allow quick action on worldwide health threats.(United States. Centers for Disease Control and Prevention)
Jun 14, 2004 ... The US Centers for Disease Control and Prevention (CDC) has unveiled a new set of goals and integrated operations designed to give the agency the ability to respond more quickly to public health threats worldwide. CDC Director Julie Gerberding, MD, announced on May 20th the ...
Clarification:.(Correction Notice)
Jun 14, 2004 ... The article on the Chiron study suggesting inhaled cyclosporine significantly increased transplant patient survival which appeared in the Business Briefs section of the May 30, 2004 issue of Transplant News was a bit misleading. The concept and clinical trials were ...
Ovarian tissue transplant results in embryo but no pregnancy.
Jun 14, 2004 ... American researchers successfully restored the fertility and endocrine function of a 30-year-old breast cancer patient after heterotopic transplantation of cryopreserved ovarian tissue, according to a report in the March 13 issue of The Lancet. The researchers removed 1 ovary ...
Blood levels only way to check drug compliance in pediatric liver recipients.(Brief Article)
Jun 14, 2004 ... Blood drug levels are the only reliable method of assessing immunosuppression adherence among pediatric and adolescent liver transplant recipients, according to an analysis published in the April issue of Pediatrics. Researchers at Mount Sinai Medical Center in New York assessed ...
Potentially useable lungs for transplant often passed over, study finds.(Brief Article)
Jun 14, 2004 ... Potentially useable donor lungs are often passed over because of out dated selection criteria that are not evidence-based, according to a new study. Current criteria for selecting lungs suitable for transplantation are "poor discriminators of pulmonary injury and infection and ...
UNOS Organ Center sets all-time record in May for placement of organs.(United Network for Organ Sharing)(Brief Article)
Jun 14, 2004 ... The United Network for Organ Sharing (UNOS) Organ Center set an all-time activity record in May by providing placement services for 610 organs, UNOS said in a press release. In addition to being the busiest month in its nearly 22-year old history, the week of May 2-8 was its busiest ...
JCAHO tissue storage and issuance lab standards have not received final approval as reported.(Joint Commission on Accreditation of Healthcare Organizations)(Brief Article)
Jun 14, 2004 ... A spokesperson for the Joint Commission on Accreditation of Healthcare Organizations' (JCAHO) says the laboratory standards for tissue storage and issuance have not undergone field review and therefore have not yet received final approval. JCAHOnline reported last month that ...
ESP Pharma, Orphan Therapeutics enter agreement to develop novel treatment for Type 1 hepato-renal syndrome.(Brief Article)
Jun 14, 2004 ... ESP Pharma, Inc., Edison, NJ, announced it has entered into an agreement with Orphan Therapeutics, LLC, Lebanon, NJ to acquire the rights to Orphan's intravenous terlipressin, a novel therapeutic in Phase III clinical trials for treating Type 1 hepato-renal syndrome (HRS). ...
Medtronic, Genzyme form joint venture to develop new treatments for cardiac repair.(Medtronic Inc.)(Genzyme Corp.)(Brief Article)
Jun 14, 2004 ... Medtronic, Inc., Minneapolis, MN, and Genzyme Corporation, Cambridge, MA announced they have formed a joint venture to accelerate the development of new treatments for some of the most intractable forms of cardiovascular disease. The companies say the new venture, which will be named MG ...
SciClone begins phase 3 Zadaxin triple therapy hepatitis C trial in Europe; achieves enrollment milestone in US.(SciClone Pharmaceuticals Inc.)
Jun 14, 2004 ... SciClone Pharmaceuticals, Inc., San Mateo, CA, announced it has begun a multi-center phase 3 hepatitis C triple therapy clinical trial in Europe. The company says its European marketing and development partner, Sigma-Tau, will conduct the Phase 3 multicenter, double blinded study in ...
2004 International Transplant Directory published annually by Transplant News available at discount price.
Jun 14, 2004 ... The 2004 International Transplant Directory, published annually by Transplant News, is available for immediate delivery. The 10th edition of the "yellow pages of transplantation" has been completely updated and contains more than 2,700 names, addresses, phone, fax, and e-mail addresses of ...